Sun Pharma, a prominent Indian pharmaceutical company, is set to establish a representative office in Turkmenistan, as disclosed during a meeting with the Turkmen Ambassador to Belarus Nazarguly Shagulyyev in Minsk on Friday.
According to the Embassy of Turkmenistan in Belarus, Sun Pharma also expresses interest in forming a joint venture for the production of medical drugs within Turkmenistan. The meeting, facilitated by the Belarusian representative office of the Indian company, featured discussions led by Narayanar Iyer.
The dialogue primarily focused on identifying promising avenues for mutually beneficial collaboration within the framework of bolstering trade and economic ties between India and Turkmenistan.
Shagulyyev briefed Iyer on Turkmenistan's legislative support for foreign investment, highlighting measures that attract and facilitate such investments. He extended an invitation for a delegation from the Indian pharmaceutical company to visit Turkmenistan, aiming to delve into specific investment proposals and forge partnership agreements.
Sun Pharmaceutical Industries Limited, based in India, stands as the world's fifth-largest pharmaceutical corporation. The company is renowned for producing affordable, high-quality medicines trusted by healthcare professionals and patients in over 150 countries.
